Clinical Trial Update: Antisecretory Factor (AF) Effects on Intraocular-pressure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Antisecretory Factor effects on intraocular pressure in glaucoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Antisecretory Factor (antisecretory factor)

Snippet

Sponsor: St. Erik Eye Hospital | Conditions: Glaucoma | Phase 3 | Status: TERMINATED